| ACS | American Cancer Society |
| AOTMiT | Agency for Health Technology Assessment and Tariff System |
| ATM | ataxia telangiectasia mutated |
| BC | breast cancer |
| BI-RADS | Breast Reporting Imaging and Data System |
| CBE | clinical breast examination |
| CC | cervical cancer |
| CDC | Centers of Disease Control and Prevention |
| CDH1 | cadherin 1 |
| CHECK2 | checkpoint kinase 2 |
| GLOBOCAN | Global Cancer Observatory |
| HDI | human development index |
| hrHPV | high-risk human papilloma virus |
| LBC | liquid-based cytology |
| LKB1 | serine/threonine protein kinase 11 |
| MMG | mammography |
| NBCCEDP | National Breast and Cervical Cancer Early Detection Program |
| NBN | nibrin |
| OB-GYN | specialist in obstetrics and gynecology |
| POU | Polish Oncology Union |
| PTEN | phosphatase and tensin homolog deleted on chromosome ten |
| SWOT | the strengths, weaknesses, opportunities, and threats |
| STK11 | serine/threonine protein kinase 11 |
| TP53 | tumor protein p53 |
| US | ultrasound |